BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Balance Sheet
NASDAQ:BMRN • US09061G1013
Current stock price
57.25 USD
+1.03 (+1.83%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 895.92M | 613.22M | 499.48M | 724.50M | 587.30M | |||
| Marketable Securities | 248.93M | 194.86M | 344.65M | 567.00M | 426.60M | |||
| Receivables | 908.21M | 660.53M | 633.70M | 461.30M | 373.40M | |||
| Inventories | 1.30B | 1.23B | 1.11B | 894.10M | 776.70M | |||
| Other Current Assets | 185.78M | 201.53M | 141.39M | 104.50M | 110.40M | |||
| Total Current Assets | 3.95B | 3.23B | 2.96B | 2.75B | 2.27B | |||
| Non-Current Assets | ||||||||
| PPE Net | 991.80M | 1.08B | 1.11B | 1.11B | 1.08B | |||
| Investments And Advances | 492.24M | 527.84M | 622.43M | 333.80M | 507.80M | |||
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M | |||
| Intangibles | 319.94M | 255.28M | 294.70M | 338.60M | 388.70M | |||
| Other Non-Current Assets | 1.64B | 1.70B | 1.66B | 1.64B | 1.55B | |||
| Total Non-Current Assets | 3.64B | 3.76B | 3.89B | 3.62B | 3.73B | |||
| TOTAL ASSETS | 7.59B | 6.99B | 6.84B | 6.38B | 6.00B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 116.00K | 341.00K | 494.02M | 2.30M | 2.30M | |||
| Accrued Expenses | 406.55M | 351.07M | 322.84M | 317.80M | 277.10M | |||
| Accounts Payable | 312.77M | 235.40M | 315.51M | 231.20M | 193.00M | |||
| Other Current Liabilities | 39.60M | 20.17M | 44.66M | 37.50M | 67.50M | |||
| Total Current Liabilities | 759.03M | 606.99M | 1.18B | 588.90M | 539.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 597.61M | 595.89M | 593.17M | 1.08B | 1.08B | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 150.38M | 128.07M | 119.86M | 99.80M | 111.70M | |||
| Total Non-Current Liabilities | 747.99M | 723.96M | 713.03M | 1.18B | 1.19B | |||
| TOTAL LIABILITIES | 1.51B | 1.33B | 1.89B | 1.77B | 1.73B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 154.21M | -194.69M | -621.55M | -789.20M | -925.70M | |||
| Additional Paid In Capital | 5.96B | 5.80B | 5.61B | 5.40B | 5.19B | |||
| Common Shares | 192.00K | 191.00K | 189.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | -27.75M | 48.60M | -39.52M | -600.00K | 6.10M | |||
| Shares Outstanding | 192.30M | 190.76M | 188.60M | 186.30M | 183.90M | |||
| Tangible Book Value per Share | 28.97 | 27.29 | 23.65 | 21.84 | 20.04 | |||
| Total Shareholders' Equity | 6.09B | 5.66B | 4.95B | 4.60B | 4.27B | |||
| TOTAL LIABILITIES AND EQUITY | 7.59B | 6.99B | 6.84B | 6.38B | 6.00B | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.11 | 0.12 | 0.24 | 0.25 | |||
| Current Ratio | 5.21 | 5.33 | 2.51 | 4.67 | 4.21 | |||
| Return On Assets (ROA) | 4.59% | 6.11% | 2.45% | 2.22% | -1.07% | |||
| Return On Equity (ROE) | 5.73% | 7.54% | 3.39% | 3.08% | -1.50% | |||
| Return On Invested Capital (ROIC) | 9.64% | 6.75% | 2.48% | 0.84% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.57% | 7.73% | 2.91% | 1.09% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 12.73% | 8.41% | 3.24% | 1.23% | N/A | |||
All data in USD , ROIC based on taxRate of 0.24